Acadia Healthcare Company (NasdaqGS:ACHC) FY Conference Summary Company Overview - Acadia Healthcare is a leading provider in the behavioral health sector, with a revenue of **$3.3 billion** for the full year of **2025** and treating **84,000 patients daily** [6][15] - The company operates **277 facilities** across **40 states**, with a diverse service offering including acute care, specialty services, residential treatment centers, and outpatient clinics [6][7] Core Business Insights - **Service Line Revenue**: - Acute care is the largest service line, contributing **70%** of revenue - Specialty services and outpatient clinics each account for **17%** of revenue - **57%** of payers are Medicaid [7][8] - **Patient Care Focus**: - Emphasis on improving patient care outcomes and safety, with ongoing investments in technology and staff training [8][9][12] - The company has added **2,500 new beds** over the last three years, with an additional **400-600 beds** expected in **2026** [10][18] Financial Performance and Projections - **Q4 Performance**: - Achieved **3.1% same-store volume growth**, an acceleration from Q3 [16] - Revenue guidance for **2026** is projected between **$3.37 billion** and **$3.45 billion**, with adjusted EBITDA between **$575 million** and **$610 million** [16][18] - **Challenges**: - Anticipated **350 basis point headwind** to same-store growth due to New York Medicaid restrictions [17] - A significant reduction in capital expenditures (CapEx) of over **$300 million** from **2025 to 2026** as new facilities are finalized [18] Operational Strategy - **Operational Excellence**: - Focus on enhancing payer relationships and ensuring appropriate reimbursement [11] - Emphasis on capital discipline and expense management for sustainable growth [11][12] - **Workforce Development**: - Aiming to recruit, retain, and train qualified staff, with improved retention rates noted [12][13] Legal and Compliance Considerations - **Malpractice Expenses**: - **$115 million** in malpractice expenses for **2025**, projected to decrease to **$100 million-$110 million** in **2026** [33] - Increased insurance costs and higher self-retention levels noted, with a focus on monitoring claims and settlements [34] Quality and Safety Initiatives - **Quality Metrics**: - Implementation of real-time tracking for incidents and outcomes at facilities to enhance patient safety [35][36] - Continuous investment in staff training to ensure high-quality patient care [38] Market Dynamics - **Demand for Services**: - Strong ongoing demand for behavioral health services, with a noted shortage of resources to meet patient needs [20] - **Outpatient Services**: - The company is focusing on expanding outpatient services, which are seen as essential for patient progression after stabilization [52][57] Conclusion - Acadia Healthcare is positioned for growth with a strong focus on operational execution, patient care, and strategic investments in facilities and workforce. The company faces challenges from regulatory changes and market dynamics but remains committed to enhancing shareholder value through improved patient outcomes and operational efficiency.

Financial Data and Key Metrics Changes - The company reported revenue of $821.5 million for Q4 2025, a 6.1% increase year-over-year [14] - Full year 2025 revenue reached $3.31 billion, reflecting a 5% increase over the prior year [15] - Adjusted EBITDA for Q4 was $99.8 million, with full year adjusted EBITDA at $608.9 million, near the upper end of guidance [15][16] - Same-facility revenue grew 4.4% year-over-year, driven by a 1.3% increase in revenue per patient day and a 3.1% increase in patient days [16] Business Line Data and Key Metrics Changes - The company added 181 beds in Q4 2025, totaling 1,089 beds added for the full year, exceeding guidance [17][18] - Startup losses related to newly opened facilities were $12.8 million in Q4, compared to $11.2 million in Q4 2024 [16] - The company plans to add between 400 and 600 new beds in 2026, primarily through new facilities [18] Market Data and Key Metrics Changes - The company is facing a $25 million-$30 million annual EBITDA impact due to New York's decision to limit Medicaid patients to in-state facilities [21][72] - The company anticipates a 2%-3% increase in same facility revenue per patient day for 2026, despite a decrease in Medicaid supplemental payment revenue [20] Company Strategy and Development Direction - The focus is on operational excellence and execution, with a commitment to support teams in the field [5][10] - The company is evaluating service lines comprehensively to ensure alignment with long-term value creation [11] - There is a strong emphasis on quality and patient safety, with a commitment to improve operational discipline and management quality [8][12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong demand for behavioral health services and the company's ability to meet that need [10][24] - The company expects full year 2026 revenue to be between $3.37 billion and $3.45 billion, with adjusted EBITDA of $575 million-$610 million [19] - Management acknowledged challenges in the operating environment but remains optimistic about unlocking EBITDA and free cash flow potential [10][24] Other Important Information - The company invested $93 million in CapEx in Q4 2025, totaling $572 million for the full year, which was nearly $50 million favorable to prior guidance [17] - The company is focused on improving relationships with referral sources and enhancing operational performance at the facility level [53] Q&A Session Summary Question: Status of the value creation review with outside advisors - Management confirmed that the review is ongoing and focused on immediate progress while also looking for long-term value opportunities [27][28] Question: Growth algorithm expectations in the current environment - Management believes the growth algorithm remains unchanged, with strong demand expected to continue [30] Question: Timeframe for realizing embedded earnings from development activity - Management indicated that the realization of the $200 million incremental EBITDA opportunity is expected within five years [35] Question: Addressing pressure on average length of stay from managed Medicaid - Management stated that they maintain stable length of stay and advocate for patients to ensure appropriate care [42] Question: Plans to rebuild trust with referral sources - Management emphasized the importance of delivering high-quality care consistently to rebuild trust with referral sources [52] Question: Long-term CapEx strategy - Management indicated a focus on improving existing facilities and being disciplined with capital expenditures moving forward [60][62] Question: Impact of California's new staffing requirements - Management expects a $4 million EBITDA impact from new staffing guidelines, which is embedded in guidance [78] Question: Observations on the ramp of new facilities - Management noted that the ramping of new facilities is being assessed on a case-by-case basis, with plans to improve processes for future openings [85]

Financial Data and Key Metrics Changes - The company reported revenue of $821.5 million for Q4 2025, a 6.1% increase year-over-year [14] - Full year 2025 revenue reached $3.31 billion, reflecting a 5% increase over the previous year [15] - Adjusted EBITDA for Q4 was $99.8 million, with full year adjusted EBITDA at $608.9 million, near the upper end of guidance [15][16] - Same-facility revenue grew 4.4% year-over-year, driven by a 1.3% increase in revenue per patient day and a 3.1% increase in patient days [16] Business Line Data and Key Metrics Changes - The company added 181 beds in Q4 2025, totaling 1,089 beds added for the full year, exceeding guidance [17][18] - Startup losses related to new facilities were $12.8 million in Q4, compared to $11.2 million in Q4 2024 [16] - The company plans to add between 400 and 600 new beds in 2026, primarily through new facilities [18] Market Data and Key Metrics Changes - The company is facing a $25 million-$30 million annual EBITDA impact due to New York's decision to restrict Medicaid patients from receiving care in out-of-state facilities [21][72] - The company anticipates a 2%-3% increase in same-facility revenue per patient day for 2026, despite a decrease in Medicaid supplemental payment revenue [20] Company Strategy and Development Direction - The focus is on operational excellence and execution, with a commitment to quality management at all levels [7][10] - The company is expanding its presence through joint ventures with leading health systems, tailoring partnerships to local community needs [9] - Capital allocation will be disciplined, with a focus on projects that stand on their own merits [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong demand for behavioral health services and the company's ability to meet that need [24] - The company is focused on improving operational discipline and leveraging data for better decision-making [56] - Management expects to generate positive free cash flow in 2026, with a significant reduction in CapEx [22][60] Other Important Information - The company has invested $93 million in CapEx in Q4 2025, totaling $572 million for the full year, which was nearly $50 million favorable to prior guidance [17] - The company is actively working to backfill occupancy in markets affected by regulatory changes [72] Q&A Session Summary Question: Update on the value creation review with outside advisors - Management confirmed that the review is ongoing and focused on immediate performance and long-term value creation [27][28] Question: Growth algorithm in the current environment - Management sees no change in the growth algorithm, with strong demand expected to continue [30] Question: Timeline for realizing embedded earnings from development activity - Management indicated that the realization of $200 million in incremental EBITDA is expected within five years [35] Question: Addressing pressure on average length of stay from managed Medicaid - Management stated that they maintain stable length of stay and advocate for patients to ensure appropriate care [42] Question: Plans to rebuild trust with referral sources - Management emphasized the importance of delivering high-quality care and maintaining strong relationships with referral sources [52] Question: Long-term CapEx strategy - Management plans to focus on existing facilities and be disciplined with capital expenditures moving forward [60][62] Question: Impact of California's new staffing requirements - Management expects a $4 million EBITDA impact from new staffing guidelines, which is embedded in guidance [78] Question: Performance of new facilities and ramp pacing - Management identified common themes affecting the ramp-up of new facilities and plans to improve processes for future openings [84]

Financial Data and Key Metrics Changes - In Q1 2025, the company's revenue was $2 million, reflecting a 25% decrease compared to the same period last year due to the loss of a customer [15] - The average revenue per enrolled member per month was approximately $254, down from $500 in Q4 2024 and $504 in Q1 2024 [17] - Gross margin for Q1 was 37%, a decrease from 61% in Q4 2024 and 63.6% in Q1 2024, primarily driven by the loss of a customer and a shift in member mix [20] Business Line Data and Key Metrics Changes - The total enrolled members reached 3,165 at the end of Q1, nearly doubling year over year, with over 1,150 members in the Engage program [6][16] - The company added 2,039 new members during the quarter, the highest since Q3 2021, contrasting with 1,641 in Q4 2024 and 925 in Q1 2024 [18] - The average monthly disenrollment rate was 10%, down from 19% in Q4 2024 and 22% in Q1 2024 [19] Market Data and Key Metrics Changes - The company has achieved state Medicaid provider approval in two states and is working to expand its footprint [8] - The outreach pool averaged 27,204 for the quarter, leading to a 30% enrollment rate, down from 50% in Q4 2024 [18] Company Strategy and Development Direction - The company aims to double its run rate revenue in 2025 compared to 2024, driven by successful conversions of prospective customers [6] - The Engage solution is expanding market reach by serving members who may not require the full Whole Health Plus program [7] - The company is focused on converting its strong pipeline into signed contracts while nurturing relationships with existing customers [13] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about converting prospective customers, particularly a large Midwestern Medicaid plan [5][10] - The overall reaction from prospects to the enhanced solution suite has been extremely positive, with health plans acknowledging the need for more intensive behavioral health support [12] - The company anticipates revenues for Q2 2025 in the range of $2.2 million to $2.6 million, representing an 8% to 22% sequential increase [22] Other Important Information - The company reported cash flow from operations for Q1 was negative $2.7 million, an improvement from negative $3.3 million in the same period last year [21] - Cash reserves stood at $4.1 million at the end of the quarter, down from $5.7 million at the end of 2024 [21] - The company has secured up to $10 million of additional financing available as needed in the short term [22] Q&A Session Summary - No specific questions or answers were documented in the provided content, indicating that the call may have concluded without a formal Q&A session.

Financial Data and Key Metrics Changes - The company reported total revenue of $52.2 million for Q1 2025, representing a 15% increase compared to Q1 2024 [22] - EBITDA increased by 153% year-over-year, reaching $2 million for the quarter [6][27] - The gross profit for the quarter was $23.3 million, up 7% from the previous year, with a gross margin of 44.6% [25] Business Line Data and Key Metrics Changes - The payer business revenue grew by 33% year-over-year, with payer sessions totaling approximately 350,000, an increase of 23% [22] - Direct to Enterprise (DTE) revenue was $9.6 million, down 3% year-over-year, while consumer revenue declined by over $2 million [25] - Unique payer members completing a session grew 17% year-over-year, reaching over 101,000 [22] Market Data and Key Metrics Changes - The company now covers nearly 200 million lives, a growth of over 40% year-over-year [23] - The Medicare population showed strong patient outcomes, with 84% of members demonstrating clinical improvement [12] Company Strategy and Development Direction - The company is focused on driving engagement within the population that has access to Talkspace through insurance plans [7] - Initiatives to enhance customer experience include real-time benefits verification and an easy button for EAP members to switch to insurance coverage [9][10] - The company is committed to expanding its psychiatry offerings and has reconfigured a dedicated team for this purpose [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the trajectory for 2025, expecting continued demand for affordable in-network care [21] - The company is not directly affected by tariffs and has shifted its core business to an insured patient base, reducing reliance on out-of-pocket spending [20] - Management noted that marketing investments are expected to yield benefits in the latter half of the year [60] Other Important Information - The company has launched AI applications to enhance client onboarding and clinical assessments, including a risk assessment tool with over 90% accuracy [18] - A partnership with BART Technologies aims to address teen mental health by providing access to Talkspace through their platform [17] Q&A Session Summary Question: How will the positive clinical data for Medicare Advantage be used to market to other MA plans? - Management noted significant interest from MA plans and the potential for developing deeper relationships with specific plans in the future [34] Question: What is the marketing budget for Medicare? - The company is taking a portfolio approach to marketing, adjusting budgets based on data-driven insights [38] Question: How broadly is the easy button for EAP to insurance switching rolled out? - The rollout is ongoing, plan by plan, and is having a significant positive impact on user engagement [43] Question: How has data retention changed with technology enhancements? - Session velocity metrics are up 5% year-over-year, indicating positive retention trends [49] Question: What portion of 2025 revenue guidance is expected from Medicare and military? - The company does not break out specific revenue sources but is optimistic about growth from these segments [47] Question: Can you discuss the Bark partnership and its economics? - The partnership allows easy access to Talkspace for Bark users, with the app preloaded on Bark phones [70] Question: How is the Talkcast feature being utilized? - The feature has generated 6,000 podcasts, with therapists deciding on their distribution to members [75] Question: What is the financial difference between EAP and insurance patients? - EAP sessions are fee-for-service, similar to insurance coverage, but insurance typically offers higher-priced sessions [82]